Pathstone Holdings »

Myriad Genetics shares owned by Pathstone Holdings

Quarter-by-quarter ownership of Myriad Genetics (MYGN) shares owned by Pathstone Holdings from 13F filings

Historical chart of Pathstone Holdings investment in Myriad Genetics

Tip: Access up to 7 years of quarterly data

All positions including Myriad Genetics held by Pathstone Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Myriad Genetics by Pathstone Holdings

Quarter filed Position value Share count Share price at filing
2025-12-31 $191k 31k 6.15
2025-09-30 $451k 62k 7.23

More positions owned by Pathstone Holdings

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Crowdstrike Hldgs Cl A (CRWD)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Rus 1000 Etf (IWB)
Amazon (AMZN)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core S&p Scp Etf (IJR)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Pathstone Holdings

Top funds holding Myriad Genetics

BlackRock
Vanguard Group
State Street Corporation
Millennium Management
Glenview Captal Management
D. E. Shaw & Co
Jacobs Levy Equity Management
Geode Capital Management
Goldman Sachs Group
Charles Schwab Investment Management
AQR Capital Management
Federated Investors
Dimensional Fund Advisors
Point72 Asset Management
Vestal Point Capital

View all funds holding Myriad Genetics